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Abstract
Objective: Decrease of olfactory function in Parkinson’s disease (PD) is a well-investigated fact. Studies indicate that
pharmacological treatment of PD fails to restore olfactory function in PD patients. The aim of this investigation was whether
patients with PD would benefit from ‘‘training’’ with odors in terms of an improvement of their general olfactory function. It
has been hypothesized that olfactory training should produce both an improved sensitivity towards the odors used in the
training process and an overall increase of olfactory function.
Methods: We recruited 70 subjects with PD and olfactory loss into this single-center, prospective, controlled non-
blinded study. Thirty-five patients were assigned to the olfactory training group and 35 subjects to the control group
(no training). Olfactory training was performed over a period of 12 weeks while patients exposed themselves twice
daily to four odors (phenyl ethyl alcohol: rose, eucalyptol: eucalyptus, citronellal: lemon, and eugenol: cloves).
Olfactory testing was performed before and after training using the ‘‘Sniffin’ Sticks’’ (thresholds for phenyl ethyl
alcohol, tests for odor discrimination, and odor identification) in addition to threshold tests for the odors used in the
training process.
Results: Compared to baseline, trained PD patients experienced a significant increase in their olfactory function, which was
observed for the Sniffin’ Sticks test score and for thresholds for the odors used in the training process. Olfactory function
was unchanged in PD patients who did not perform olfactory training.
Conclusion: The present results indicate that olfactory training may increase olfactory sensitivity in PD patients.
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Introduction
Impairment of olfaction is a characteristic and early feature of
Parkinson’s disease (PD). Recent data indicate that .95% of
patients with PD present with significant loss of olfactory
function [1] whose impact on daily life is often underappreci-
ated [2]. The sense of smell makes a significant contribution to
the quality of life and the ability to experience pleasure.
According to a study by Politis et al. [3] olfactory loss belongs to
the top-five most prevalent motor and non-motor symptoms in
early stage PD patients that affect their quality of life. Only pain
is referred to as a more prevalent troublesome non-motor
problem in this patient group. Specifically, patients with
impaired olfaction are more likely to experience depressive
symptoms as they express severe limitations in relation to the
enjoyment of food and drinks and socializing [4], [5].
Despite of the high prevalence of olfactory impairment in PD
which even exceeds the prevalence of tremor 1 no therapy has yet
been proven to be effective in PD-related smell loss. Studies
indicate that pharmacological treatment of PD fails to restore
olfactory function in PD patients [6], [7]. While appropriate
investigations in larger groups of PD patients with olfactory
function appear to be missing, dopamine agonists do not appear
to have a significant effect on olfactory function in PD [8].
Recently, however, deep brain stimulation (DBS) has been
added to the therapeutic armamentarium in PD. The study by
Hummel et al. [9] indicates that DBS in PD patients improves
odor discrimination while it has no effect on odor thresholds.
These results are partly confirmed by a study in 15 patients [10]
and a case report [11] where the identification of odors was
found to become more precise during the ON period of the
stimulator. Understandably, this therapeutic approach cannot
be applied on a routine basis. Results are however consistent
with previous studies suggesting that the olfactory sense has the
ability to change and recover. In this context olfactory training
has been shown to improve olfactory function in humans [12–
14] and is now an acknowledged therapy in postinfectious and
posttraumatic smell loss.
The goal of this single center, prospective, controlled, non-
blinded study was to investigate the change of olfactory function in
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PD patients following olfactory training for 12 weeks consisting of
frequent short-term exposure to various odors.
Materials and Methods
Subjects
Thirty five training subjects were recruited consecutively
between May 2010 and August 2011 and 35 control subjects
between May 2009 and May 2010 at the Division of Neurode-
generative Diseases, Department of Neurology at Dresden
University of Technology. The control subjects participated in a
longitudinal olfactory study. Eligible subjects were 18 years of age
or older, had received the diagnoses of PD according to UK Brain
Bank criteria [15], and were on stable anti-parkinsonian medica-
tion for at least 4 weeks prior to study enrollment and during the
study. The following exclusion criteria had been defined:
Identifiable cause of parkinsonism or signs for atypical parkinso-
nian disorders, dementia, and psychiatric conditions interfering
with study participation.
Detailed information about the experiment was given to all
participants and written consent was obtained. All aspects of the
study were performed in accordance with the Declaration of
Helsinki. The study protocol was approved by the local Ethics
Board of the Faculty of Medicine of Dresden University of
Technology.
Training with Odorants
The training group performed olfactory training over a period
of 12 weeks. Patients exposed themselves twice daily to four odors
(phenyl ethyl alcohol (PEA): rose, eucalyptol: eucalyptus, citronel-
lal: lemon, and eugenol: cloves). These four odorants were chosen
to be representative of four odor categories claimed by Henning
[16] in his work on the ‘‘odor prism’’ (Geruchsprisma), where he tried
to identify primary odors (compare [17]). These categories are
flowery: blumig (e.g., rose), foul: faulig, fruity: fruchtig (e.g., lemon),
aromatic: wu¨rzig (e.g., cloves), burnt: brenzlig, and resinous: harzig
(e.g., eucalyptus). Training patients received four brown glass jars
(total volume 50 mL) with one of the four odors in each (1 mL
each, soaked in cotton pads to prevent spilling). All jars were
labeled with the odor name. Patients were asked to sniff the odors
in the morning and in the evening for approximately 10 seconds
each. To focus their attention on the training, they were asked to
keep a diary in which they rated their overall olfactory abilities
each Sunday (data not analyzed). Further, patients received a
phone call by one of the experimenters 4 weeks after the training
started (1) to ask about the patients’ olfactory function and (2) to
maintain compliance with the training procedure. Patients in the
non-training group were advised to wait and see how the olfactory
function would change.
Olfactory Testing
Olfactory testing was performed before and after the training
period of 12 weeks using the ‘‘Sniffin’ Sticks’’ test kit [18] which
involves tests for odor threshold, odor discrimination, and odor
identification. Using commercially available felt-tip pens, the
odorants were presented approximately 2 cm in front of both
nostrils for 2 seconds. PEA odor threshold was assessed by a
single-staircase, 3-alternative forced choice (3-AFC) procedure.
Three pens were presented to the patient in a randomized order,
two contained odorless solvent (propylene glycol) and the other an
odorant in a certain dilution. The patient’s task was to indicate the
pen with the odorant. Concentration was increased if one of the
blanks was chosen and decreased if the correct pen was identified
twice in a row. The mean of the last 4 of a total of 7 reversal points
was used as detection threshold (ranging from 1 to 16). A total of
16 odor concentrations were tested starting from a 4% stock
solution (dilution ratio 1:2; solvent propylene glycol). The second
subtest assessed the ability of the patient to discriminate different
odors. Again, 16 triplets of pens were offered, each including two
identical odors and a different one. The patient’s task was to
indicate the pen which had a different smell. The score was the
sum of correct responses ranging from 0 to 16. Both threshold and
discrimination testing was performed with the patient being
blindfolded. For testing of odor identification, 16 pens containing
common odors were offered. The patient had to identify each of
the odorants from a list of four descriptors. The sum of the scores
from the three subtests resulted in the TDI-score (Threshold,
Discrimination, Identification) with a maximum of 48 points. A
score of 30.5 points or more indicates normosmia, a score between
16.5 and 30 points indicates reduced olfactory function in terms of
hyposmia, and a score of less than 16.5 points indicates functional
anosmia.
Threshold Measures
While thresholds for PEA were measured using the single-
staircase paradigm within the Sniffin’ Sticks test kit (see previously
discussed data), thresholds for the other odorants used for training
(eucalyptus, eugenol, and citronellal) were assessed by means of the
method of ascending limits [19], using a 3-AFC procedure. This
procedure was chosen because it is slightly faster than the staircase
procedure, although it may be somewhat less reliable [20]. Odors
were presented in brown glass jars, similar to the presentation of
PEA using the ‘‘Sniffin’ Sticks’’. Two of the jars contained odorless
solvent (propylene glycol), the other an odorant in a certain
concentration. The patient’s task was to indicate the jar with the
odorant. Correct identification was assumed when the patient
correctly identified the same odor concentration three times in a
row. A total of eight odor concentrations for each odor were tested
starting from 4% stock solutions (dilution ratio 1:4; solvent
propylene glycol). Between tests of the odorants, subjects rested
for approximately 5 minutes to minimize adaptation.
Statistical analyses
Data were analyzed by means of SPSS 19.0 (SPSS Inc.,
Chicago, Ill, USA). If not mentioned otherwise, all data are
displayed as means6standard deviation (SD) or numbers (%),
significance level was set at p,0.05 (two-tailed test). Bonferroni




Thirty-five patients (18 men, 17 women; mean6SD age:
63.168.2 yrs (range: 43–76 yrs); mean6SD disease duration;
7.564.8 yrs; median Hoehn & Yahr stage: 2 (range: 1–4))
participated in the ‘‘training group’’. In the ‘‘control group’’
35 patients participated (27 men, 8 women; mean6SD age:
61.569.5 yrs (range: 45–76 yrs); mean6SD disease duration:
3.863.1 yrs; median Hoehn & Yahr stage: 1.9 (range: 1–3)).
Descriptive statistics of the patient groups are shown in Table 1.
‘‘Training group’’
Psychophysics. Olfactory function expressed as TDI score
was significantly different between baseline and after 12 weeks of
training (t(35) =23.37, p = 0.002; Figure 1). With regard to
individual tests of olfactory function there was an effect of the
factors ‘‘olfactory training’’ (F(1,34) = 6.67, p = 0.014), and ‘‘olfac-
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tory test’’ (F(2,32) = 125.26, p = 0.001) indicating that the training
effect was reflected by the subtests in a different way. This was also
indicated by post-hoc testing with paired two-sided t-tests which
revealed that the groups differed for odor discrimination
(t(35) = 2.5, p= 0.016), and that the groups tended to be different
for odor identification (t(35) = 1.9, p = 0.065); no group difference
was present for odor threshold (t(35) = 1.2, p = 0.24; Figure 1). In
addition, thresholds for the other odorants used for training
(eucalyptus, eugenol, and citronellal) improved significantly after
the training period: eucalyptus t(35) = 3.05, p = 0.004; eugenol
t(35) = 4.3, p= 0.001); citronellal t(35) = 3.97, p = 0.001 (Figure 2).
Sex-and age-related differences in olfactory
improvement. Furthermore, when comparing TDI score
difference between male and female PD patients, no significance
was seen (t = 0.98, p = 0.34). Correlational analyses between TDI
score difference(baseline-12 weeks) in relation to the age of the patients
revealed no significant correlations (r = 0.02, p = 0.94).
Relationship between olfactory improvement and
severity/duration of disease. Correlational analyses between
TDI score difference(baseline-12 weeks) in relation to the severity of
PD were made across all patients and, separately, for hyposmic
patients only. However, there were no significant correlations
(Pearson) between the TDI score difference, duration of disease
(r =20.18, p = 0.92), Hoehn & Yahr score (r =20.07, p = 0.69),
the UPDRS-III score (r =20.01, p= 0.95) and the UPDRS-III
score difference(baseline-12 weeks) (r =20.06, p = 0.76), respectively.
Duration of the disease correlated significantly with Hoehn &
Yahr score (r = 0.48, p = 0.001). When comparing UPDRS-III
score before and after olfactory training no significant difference
was found (t = 0.98, p = 0.34).
Differences between PD subtypes. With regard to the
olfactory improvement there were significant differences between
patients with different disease subtypes (tremor dominant type
(n = 6), akinetic-rigid type (n = 13) or mixed type (n = 16)
(F(2,32) = 4.46, p = 0.02). Hereby, the olfactory improvement
was largest in tremor dominant type PD patients although baseline
TDI scores proved not to be different between the groups (p = 0.8).
Controls
Psychophysics. When assessed by means of the ‘‘Sniffin’-
Sticks’’ birhinal olfactory performance was not significantly
different between baseline and after 12 weeks (TDI: t(35) = 0.14,
p = 0.891; threshold: t(35) =20.60, p = 0.55; discrimination:
t(35) = 1.03, p = 0.31; identification: t(35) = 0.367, p= 0.72;
Figure 1).
‘‘Training group’’ vs Controls
Psychophysics improvement. When comparing TDI score
differences between baseline and after 12 weeks between controls
and the training group the latter group performed significantly
better (F(1,68) = 10.41, p = 0.005). With regard to individual
subtests only odor discrimination was significantly different
between the two groups (F(1,68) = 10.25, p = 0.002), but not odor
threshold (F(1,68) = 0.74, p = 0.34) and odor identification
(F(1,68) = 20.63, p = 0.09; Figure 3). Furthermore, with regard to
improvement on an individual level [21], seven of 35 subjects from
the training group (20%) exhibited improvement of more than 5.5
points in the TDI score, whereas only 3 of 35 subjects exhibited
improvement in the control group (9%) (Figure 4). Two of the
patients in the training group (6%) exhibited a decline of olfactory
function whereas this was the case in 4 patients (11%) in the
control group.
Discussion
Our results indicated that A) olfactory training produces both
an improved sensitivity towards the odors used in the training
process and an overall increase of olfactory function. It appears to
increase olfactory function in 20% of the subjects over a period of
12 weeks compared to 9% of subjects who had no olfactory
training. (B) Olfactory training proves to be useful independently
from age, sex, duration and severity of the disease, and severity of
olfactory dysfunction. (C) The training effect appears to be more
pronounced in patients with tremor dominant type of PD.
These findings are consistent with the results of previous studies
suggesting that the olfactory sense has the ability to change and
recover. Such plasticity has been shown in animals e.g., for the
odorant androstenone [22], a five odorant identification task [23],
and comprehensive odorant detection training [24]. In the latter
study, odorant-guided operant conditioning training proved
sufficient to restore olfactory detection performance in cadmium-
exposed mice with damaged olfactory function. Furthermore,
Table 1. Descriptive statistics of patients groups.
Training group (n =35) Control group (n =35) p-valuea
Age (years) 63.168.3 61.569.5 0.10
Sex (n) 17 R, 18= 8 R, 27= 0,03
Duration of disease (years) 7.564.8 3.863.1 0.001
Hoehn & Yahr scoreb 2.0 [1–4] 1.9 [1–3] 0.52
TDIt=0 score 18.165.3 17.865.2 0.89
threshold t=0 score 2.461.9 2.862.3 0.55
discrimination t=0 score 8.162.7 7.062.6 0.31
identification t=0 7.662.7 7.862.2 0.72
TDI t =12 weeks score 20.565.4 17.264.8 0.012
threshold t=12 weeks score 2.962.3 2.662.1 0.67
discriminationt=12 weeks score 9.262.3 6.662.5 0.001
identification t=12 weeks score 8.662.4 7.761.9 0.12
ap-values are from unpaired two-sided t-tests.
bMedian [range].
doi:10.1371/journal.pone.0061680.t001
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repeated exposure of human subjects to androstenone [25], which
has been shown by means of psychophysical and electrophysio-
logical techniques supported the existence of plasticity in the
peripheral olfactory system which may be reflected by an
increased growth of olfactory receptor neurons and/or an
increased expression of olfactory receptors in response to the
exposure.
It is interesting to note that odor discrimination, but not odor
threshold, improved in response to olfactory training. An
explanation could be that odor discrimination appears to involve
higher-level cognitive functions compared to odor thresholds (e.g.,
[26,27]), especially as odor memory is intimately involved in the
non-verbal odor discrimination paradigm. Support for our results
comes from animal research [28] where rats were given extensive
training with overlapping complex odorant mixtures and conse-
quently showed improved behavioral discrimination abilities.
Therefore, it might be hypothesized that olfactory training has
positive effects on cognitive processing of olfactory information.
Likewise, the observed effect may reflect improved attention to
odors induced by the intense focus on odors during the training
period. Motor function however, as reflected by the UPDRS
motor score remains unchanged.
Figure 1. Olfactory function as expressed by the TDI score (comprehensive score of threshold, discrimination, and identification
abilities) at baseline and after 12 weeks in the training group and the control group without training. Higher scores express higher
olfactory sensitivity.
doi:10.1371/journal.pone.0061680.g001
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Figure 2. Threshold testing of the training odors citronellal, eucalyptol and eugenol before and after olfactory training. Higher odor
thresholds express higher olfactory sensitivity.
doi:10.1371/journal.pone.0061680.g002
Figure 3. Change of olfactory function after 12 weeks as expressed by the TDI score (comprehensive score of threshold,
discrimination, and identification abilities) in the training group compared to controls without training.
doi:10.1371/journal.pone.0061680.g003
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In our study we observed an age- and sex-independent
response to olfactory training which was also not influenced by
the duration and the severity of the disease. Consequently, PD
patients equally qualify for olfactory training. With regard to the
different disease subtypes however, tremor dominant PD
patients had the greatest benefit from training. Katzen et al.
[29] and Oh et al. [30] reported that PD patients with tremor-
dominant subtype had the best cognitive function state and
showed superior performance on overall cognitive function
tasks, including language, memory ability and execution
function. Considering the proposed close association between
cognitive and olfactory functioning it might be hypothesized
that the baseline cognitive state is determining the olfactory
outcome. On the other hand, however, in terms of general
olfactory function there are no major differences between
subtypes of PD, namely tremor-dominant PD, akinetic-rigid PD,
and equivalent-type PD [1].
Although our results seem to suggest that olfactory training may
be helpful in PD patients with olfactory loss, they also raise
numerous questions. One limitation of our study is that we used a
non-blinded design. Future blinded studies need to determine 1)
whether the observed increase of olfactory sensitivity is temporary
or would stay even after the training period is over; 2) whether
patients need to train with odors, or whether sniffing alone leads to
the same results; 3) whether training with odors increases cognitive
function of PD patients; and 4) whether training leads to an
increase of the volume of the olfactory bulb or the responsiveness
to odors at the level of the olfactory epithelium. These future
studies will also have to use more balanced groups in terms of the
disease subtype.
In conclusion, our results indicate that the structured, short-
term exposure to odors may increase olfactory sensitivity in PD
patients.
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